# Reliance Life Sciences Private Limited, Navi Mumbai, India – FDA Inspections

Source: https://www.keypedia.com/companies/reliance-life-sciences-private-limited/14b16d70-e482-4647-a231-4eb4a1aab98f

> Inspection records and compliance data for Reliance Life Sciences Private Limited in Navi Mumbai. 10 FDA inspections on record (1 OAI), 4 Form 483s, 1 warning letter, last inspected February 27, 2026.

---

## Details

- Name: Reliance Life Sciences Private Limited
- FEI Number: 3009510975
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK
- Address Line 1: Ttc Area Of Midc, R - 282 Dhirubhai Ambani Life Sciences Centre; Thane Belapur Road
- City: Navi Mumbai
- Country Name: India
- Address: Ttc Area Of Midc, R - 282 Dhirubhai Ambani Life Sciences Centre; Thane Belapur Road, Navi Mumbai, India
- Country: India

## Related Documents

- [WARNING_LETTER - Reliance Life Sciences Private Limited - 2026-02-27](https://www.keypedia.com/records/warning_letter/reliance-life-sciences-private-limited/ba7fe25d-ffe5-4555-a2f6-20bff3df6625) — source: FDA, date: February 27, 2026
- [483 - Reliance Life Sciences Private Limited - 2026-02-27](https://www.keypedia.com/records/483/reliance-life-sciences-private-limited/43ee35e0-0c20-4849-9f73-a6f046f78841) — source: FDA, date: February 27, 2026
- [FDA Inspection 1311632 - Reliance Life Sciences Private Limited - 2026-02-27](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/ccab4917-175f-46db-ad0c-ba158ab3159d) — source: FDA, date: February 27, 2026
- [FDA Inspection 1170339 - Reliance Life Sciences Private Limited - 2022-04-15](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/25bd4384-4ea7-4998-8065-2fb38edb15d1) — classification: No Action Indicated (NAI), source: FDA, date: April 15, 2022
- FDA Inspection 1113122 - Reliance Life Sciences Private Limited - 2019-11-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2019
- [FDA Inspection 1081821 - Reliance Life Sciences Private Limited - 2019-02-22](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/f95a3d58-e9f3-4080-8e57-56a6cf432d59) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 22, 2019
- FDA Inspection 1070144 - Reliance Life Sciences Private Limited - 2018-10-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 16, 2018
- [FDA Inspection 1070144 - Reliance Life Sciences Private Limited - 2018-10-16](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/f81e0521-c3a6-4bcf-9fb0-651407a13902) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 16, 2018
- FDA Inspection 1047623 - Reliance Life Sciences Private Limited - 2018-01-25 — classification: No Action Indicated (NAI), source: FDA, date: January 25, 2018
- [FDA Inspection 1035956 - Reliance Life Sciences Private Limited - 2017-12-13](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/568afd53-47df-4520-baef-a07fc7d6165e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 13, 2017
- FDA Inspection 1038719 - Reliance Life Sciences Private Limited - 2017-12-11 — source: FDA, date: December 11, 2017
- [FDA Inspection 940150 - Reliance Life Sciences Private Limited - 2015-08-14](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/31fccf0e-5d28-486d-93c4-e941ab976fbf) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 14, 2015

## Related Companies

- [Genentech, Inc.](https://www.keypedia.com/companies/genentech-inc/709aa262-e8df-42fa-bec6-02673e7f52ec)
- [Taro Pharmaceutical Industries, Ltd.](https://www.keypedia.com/companies/taro-pharmaceutical-industries-ltd/75bff305-a575-43eb-9c35-401fed5479be)
- [Shandong Anxin Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/shandong-anxin-pharmaceutical-co-ltd/1bbdc465-0634-4e76-994f-a57ad864fc33)
- [Aprecia Pharmaceuticals LLC](https://www.keypedia.com/companies/aprecia-pharmaceuticals-llc/126049a3-6c3d-4616-8d44-006827a308c3)
- [Shionogi Pharma Co., Ltd.](https://www.keypedia.com/companies/shionogi-pharma-co-ltd/bb3e5dcd-52f9-4971-9747-4c04b63ba0fa)
- [Merck Serono SA](https://www.keypedia.com/companies/merck-serono-sa/11522eec-8d30-492a-90ba-09b167899bdc)
- [Actavis Elizabeth LLC, A Company of Teva](https://www.keypedia.com/companies/actavis-elizabeth-llc-a-company-of-teva/c4a12fda-d6c3-4ad3-bac5-cc2b5695950e)
- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)
- [F. Hoffmann - La Roche Ltd.](https://www.keypedia.com/companies/f-hoffmann-la-roche-ltd/622e8fa3-95f3-4ed9-a1bd-99dc0748f273)
- [Xellia Pharmaceuticals ApS](https://www.keypedia.com/companies/xellia-pharmaceuticals-aps/5d9704ca-114e-4a65-abca-966a5c4e2a57)

## Related Officers

- [Ashar P. Parikh](https://www.keypedia.com/people/ashar-p-parikh/f5430c51-31c7-44bb-90f7-1ec8ae581343)
- [Eileen A. Liu](https://www.keypedia.com/people/eileen-a-liu/fa051db4-1242-4181-9af9-5b3cd2de5689)
- [Director](https://www.keypedia.com/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)
